CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- Open-market buys, last 90 days
- $44,466
- in 11 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$44,466. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-08-15 | Rodino Peter W. III Dir Govt Relations/Sectry | Grant or award · Options to buy Common Stock | +9,957 | $0.29 | $3K | 9,957 |
| 2017-08-15 | Equels Thomas K. CEO / President | Grant or award · Options to buy Common Stock | +21,336 | $0.29 | $6K | 21,336 |
| 2017-08-15 | Springate Wayne S. Sr. VP of Operations | Grant or award · Options to buy Common Stock | +6,401 | $0.29 | $2K | 6,401 |
| 2017-08-15 | Pascale Adam CFO | Grant or award · Options to buy Common Stock | +7,112 | $0.29 | $2K | 7,112 |
| 2017-07-31 | Appelrouth Stewart Director | Grant or award · Options to buy Common Stock | +25,284 | $0.30 | $8K | 25,284 |
| 2017-07-31 | MITCHELL WILLIAM M Director | Grant or award · Options to buy Common Stock | +25,284 | $0.30 | $8K | 25,284 |
| 2017-07-31 | Equels Thomas K. CEO / President | Grant or award · Options to buy Common Stock | +20,786 | $0.30 | $6K | 20,786 |
| 2017-07-31 | Rodino Peter W. III Dir Govt Relations/Sectry | Grant or award · Options to buy Common Stock | +9,700 | $0.30 | $3K | 9,700 |
| 2017-07-31 | Springate Wayne S. Sr. VP of Operations | Grant or award · Options to buy Common Stock | +6,236 | $0.30 | $2K | 6,236 |
| 2017-07-31 | Pascale Adam CFO | Grant or award · Options to buy Common Stock | +6,929 | $0.30 | $2K | 6,929 |
| 2017-07-15 | Appelrouth Stewart Director | Grant or award · Options to buy Common Stock | +22,047 | $0.34 | $7K | 22,047 |
| 2017-07-15 | MITCHELL WILLIAM M Director | Grant or award · Options to buy Common Stock | +22,047 | $0.34 | $7K | 22,047 |
| 2017-07-15 | Rodino Peter W. III Exec Dir Govt Relations/Sectry | Grant or award · Options to buy Common Stock | +8,458 | $0.34 | $3K | 8,458 |
| 2017-07-15 | Equels Thomas K. CEO / President | Grant or award · Options to buy Common Stock | +18,124 | $0.34 | $6K | 18,124 |
| 2017-07-15 | Springate Wayne S. Sr. VP of Operations | Grant or award · Options to buy Common Stock | +5,438 | $0.34 | $2K | 5,438 |
| 2017-07-15 | Pascale Adam CFO | Grant or award · Options to buy Common Stock | +6,042 | $0.34 | $2K | 6,042 |
| 2017-06-30 | Appelrouth Stewart Director | Grant or award · Options to buy Common Stock | +17,290 | $0.44 | $8K | 17,290 |
| 2017-06-30 | MITCHELL WILLIAM M Director | Grant or award · Options to buy Common Stock | +17,290 | $0.44 | $8K | 17,290 |
| 2017-06-30 | Rodino Peter W. III Exec Dir Govt Relations/Sectry | Grant or award · Options to buy Common Stock | +6,633 | $0.44 | $3K | 6,633 |
| 2017-06-30 | Equels Thomas K. CEO / President | Grant or award · Options to buy Common Stock | +14,214 | $0.44 | $6K | 14,214 |
Page 17 of 19 · 376 trades